SCHEMBL13764876

SCHEMBL13764876

COc1ccc(C(Nc2ccc(CN)cc2)[C@@H](CC[C@H](OC)c2ccc(F)cc2)C(=O)N(C)[C@@H](C)[C@@H](O)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 11/20 0.46
KMT2A Q03164 3/20 0.40
LMNA P02545 3/20 0.40
MEN1 O00255 2/20 0.40
HTT P42858 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CRHBP P24387 1/20 0.40
CYP2C19 P33261 1/20 0.40
CRHR2 Q13324 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KLK7 P49862 1/20 0.39
NPY2R P49146 1/20 0.39
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4000734 0.92 NPY5R (0.47) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL13764904 0.92 NPY5R (0.47) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL5158316 0.92 NPY5R (0.47) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL13764898 0.91 NPY5R (0.42) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL13764899 0.91 NPY5R (0.42) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL4000662 0.90 NPY5R (0.41) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL13764882 0.88 NPY5R (0.42) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL13764897 0.87 NPY5R (0.39) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL4005280 0.83 NPY5R (0.40) NPY5RKMT2ALMNAMEN1HTT
SCHEMBL13764888 0.82 KMT2A (0.43) KMT2ALMNAMEN1HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563888-B2 Process for the preparation of diphenyl azetidinone derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-07-21 US disclosed
US-20070149501-A1 PROCESS FOR THE PREPARATION OF DIPHENYL AZETIDINONE DERIVATIVES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149501-A1 PROCESS FOR THE PREPARATION OF DIPHENYL AZETIDINONE DERIVATIVES CYP46A1, APOB, DHCR7 NPY5R 714/4885KMT2A 1869/4885LMNA 912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.